慶應義塾研究者情報データベース

経歴 【 表示 ／ 非表示 】

経歴 【 表示 ／ 非表示 】

• 2015年04月

  -

  継続中

  慶應義塾大学医学部小児科学教室, 助教

学歴 【 表示 ／ 非表示 】

学歴 【 表示 ／ 非表示 】

• 2002年04月

  -

  2008年03月

  慶應義塾大学, 医学部

  大学, 卒業

• 2018年04月

  -

  2022年03月

  慶應義塾大学, 医学部, 医学研究科博士課程

  大学院, 修了, 博士

学位 【 表示 ／ 非表示 】

学位 【 表示 ／ 非表示 】

• 博士（医学）, 慶應義塾大学, 課程, 2022年03月

免許・資格 【 表示 ／ 非表示 】

免許・資格 【 表示 ／ 非表示 】

• 小児科専門医, 2013年10月

• 周産期（新生児）専門医, 2016年12月

• 臨床遺伝専門医, 2024年11月

研究分野 【 表示 ／ 非表示 】

研究分野 【 表示 ／ 非表示 】

• ライフサイエンス / 遺伝学 （ゲノムインプリンティング）

• ライフサイエンス / 胎児医学、小児成育学

研究キーワード 【 表示 ／ 非表示 】

研究キーワード 【 表示 ／ 非表示 】

• インプリンティング異常症

• ビタミンD

• 新生児学

論文 【 表示 ／ 非表示 】

論文 【 表示 ／ 非表示 】

• Impact of COVID-19-Related Social Restrictions on Vitamin D Levels in Japanese Newborns and Infants: A Retrospective Cohort Study.

  Seki Y, Hara-Isono K, Morisawa K, Hida M, Ikeda K

  The Keio journal of medicine 2026年07月

  ISSN  0022-9717

  • Access to Document (DOI)

• Bidirectional changes in serum 25-hydroxyvitamin D in newborns during the first four days of life: A longitudinal cohort study.

  Ikeda K, Hara-Isono K, Morisawa K, Abe K

  Clinical nutrition ESPEN 73   103289 2026年04月

  　概要を見る

  Background & aims Little is known about short-term vitamin D dynamics during the immediate neonatal period. Most neonatal studies have relied on single-point measurements of 25-hydroxyvitamin D (25(OH)D), limiting understanding of early postnatal changes. In Japan, healthy full-term infants typically remain hospitalized for 4–5 days, receiving minimal vitamin D intake from small amounts of formula and experiencing virtually no sunlight exposure. This clinical setting provides a unique opportunity to investigate early postnatal vitamin D dynamics under conditions of minimal exogenous input. This study aimed to examine short-term changes in serum 25(OH)D from birth to day 4 of life (Δ25(OH)D) and determine how baseline vitamin D status influences these changes. Methods We analyzed 40 infants with paired cord blood and day 4 serum 25(OH)D measurements obtained by chemiluminescence immunoassay. Linear regression evaluated the association between cord blood 25(OH)D concentrations and Δ25(OH)D. Results Estimated vitamin D intake during hospitalization was 64 ± 18 IU/day, substantially below the 400 IU/day recommended by the American Academy of Pediatrics. Baseline-dependent bidirectional changes in serum 25(OH)D were observed: infants with lower cord blood concentrations increased, whereas those with higher baseline concentrations declined. Cord blood 25(OH)D concentrations were strongly inversely correlated with Δ25(OH)D (r = −0.745, p < 0.001). Regression analysis indicated an equilibrium point of approximately 21.4 ng/mL, at which no net change in serum 25(OH)D was expected. Conclusion This study provides the first quantitative description of short-term changes in neonatal 25(OH)D after birth and suggest dynamic physiological regulation of vitamin D during early life.

  • Access to Document (DOI)

• Weekly vitamin D supplementation during early infancy as a potential strategy to prevent vitamin D insufficiency: A two-center retrospective study

  Hara-Isono K., Morisawa K., Hida M., Iwamoto S., Ikeda K.

  Pediatrics and Neonatology 67 （ 2 ） 203 - 209 2026年03月

  ISSN  18759572

  　概要を見る

  Background: For preventing Vitamin D (VD) insufficiency, several VD supplementation guidelines were established worldwide. In Japan, no nationwide guidelines for preventing VD insufficiency have been implemented, whereas guidelines for preventing vitamin K (VK) deficiency-related bleeding recommend weekly supplementation of VK. The aim of this study is to clarify whether weekly VD plus VK supplementation during the early neonatal period prevents VD insufficiency at one month of age.MethodsWe retrospectively analyzed serum 25-hydroxyvitamin D (25(OH)D) levels of 555 one-month-old infants born between 2017 and 2023. Infants were classified into the control group (not supplemented), weekly group (1000 IU/week), and daily group (240 IU/day). We compared serum 25(OH)D levels among the three groups. Multivariable logistic regression analyses adjusted for formula intake and BMI were performed to better estimate the effect of VD supplementation on the prevention of VD insufficiency.ResultsWe included 414, 55, and 86 infants in the control, weekly, and daily groups, respectively. All infants received weekly supplementation of VK. Serum 25(OH)D levels in the weekly and daily groups were higher than those in the control group (median (ng/mL): control 9.7 vs weekly 22.2, P < 0.001; control vs daily 23.0, P < 0.001). The frequencies of VD insufficiency were 370/414 (89.4 %), 11/55 (20.0 %), and 22/86 (25.6 %) in the control, weekly, and daily groups, respectively. Adjusted odds ratios of VD insufficiency compared to the control were 0.038 (95 % confidence intervals (95 %CI): 0.017, 0.085) and 0.036 (95 %CI: 0.019, 0.067) in the weekly and daily groups, respectively. No infant with VD excess was observed.ConclusionOur results demonstrated that combined weekly supplementation of VD and VK during early infancy can prevent VD insufficiency at one month of age without causing VD excess. This finding may provide evidence for the development of nationwide prophylaxis for VD insufficiency in regions lacking specific guidelines.

  • Access to Document (DOI)

• Effects of maternal commercial supplementation on 25-hydroxyvitamin D levels in newborns: a retrospective cohort study in a single center, Saitama, Japan, 2022–2023

  Morisawa K., Ikeda K., Hida M., Hara-Isono K.

  Endocrine Journal 73 （ 2 ） 243 - 249 2026年

  ISSN  09188959

  　概要を見る

  Vitamin D (VD) insufficiency in pregnant women is a serious health problem worldwide. To prevent VD insufficiency during pregnancy, several guidelines recommend 600 IU/day VD for all pregnant women. In Japan, no national guidelines for preventing VD insufficiency have been implemented, and no study has evaluated adequate VD intake in pregnant women; however, the number of pregnant women taking commercial dietary supplements containing VD has increased in recent years. This study aimed to examine the effects of maternal commercial supplementation of VD on 25-hydroxyvitamin D (25(OH)D) levels in newborns. We retrospectively analyzed the serum 25(OH)D levels in 279 four-days-old newborns born at the Saitama City Hospital from 2022 to 2023. Newborns were classified into a supplement group (mothers who took VD-containing commercial supplements regularly throughout pregnancy; n = 103) and a non-supplement group (mothers who did not take any supplements during pregnancy; n = 176). The study findings revealed that serum 25(OH)D levels in newborns in the supplement group were higher than those in the non-supplement group (median [interquartile range]: supplement group 17.2 [14.6, 22.9] vs. non-supplement group 14.3 [11.6, 16.7], p < 0.001). In the supplement group, approximately 70% of newborns still showed VD insufficiency. Although the maternal use of VD-containing commercial supplements during pregnancy increased the serum 25(OH)D levels in newborns at four days of age, additional measures, such as VD supplementation for newborns, are needed to improve neonatal VD status.

  • Access to Document (DOI)

• Age-dependent discordance in chemiluminescent immunoassay-electrochemiluminescence immunoassay correlation for 25-hydroxyvitamin D measurement reveals methodological considerations for assessment in early infancy

  Ota M., Ikeda K., Morisawa K., Nakagawa T., Hida M., Hara-Isono K.

  Endocrine Journal 73 （ 4 ） 563 - 570 2026年

  ISSN  09188959

  　概要を見る

  Vitamin D (VD) status is assessed by measuring serum 25-hydroxyvitamin D (25(OH)D) levels using immunoassays. In December 2024, a Japanese diagnostic laboratory transitioned from chemiluminescent immunoassay (CLIA: LIAISON^® 25 OH Vitamin D Total Assay) to an electrochemiluminescent immunoassay (ECLIA: Elecsys^® Vitamin D Total III assay). Although these methods yield comparable results in adults, it remains unclear whether this applies to children, particularly newborns and infants. This study aims to clarify the impact of transition from CLIA to ECLIA on 25(OH)D levels during early infancy. Serum 25(OH)D levels were measured in 84 infants under three months old (67 under four days old) using both CLIA and ECLIA. Correlation and agreement were assessed using Passing–Bablok regression and Bland–Altman analyses, respectively. The obtained regression equation was applied to 252 age- and sex-matched cases from 2,253 historical controls in the registry to evaluate changes in VD classification. The regression equation was Y<inf>ECLIA</inf> = 0.846X<inf>CLIA</inf> – 2.281 (τ = 0.53, p < 0.001). Bland–Altman analysis revealed a constant negative bias of –4.89 ± 3.53 ng/mL [–5.66, –4.12] (mean ± standard deviation [95% confidence interval]) for ECLIA versus CLIA. Reclassification revealed an increase in VD deficiency (25(OH)D < 12 ng/mL) from 27.8% to 61.9%, and VD insufficiency (25(OH)D < 20 ng/mL) from 75.4% to 91.7%. The transition from CLIA to ECLIA led to lower measured 25(OH)D levels in newborns and infants and increased VD deficiency and insufficiency diagnoses. Method-specific differences should be considered when evaluating VD status during early infancy, particularly in infants under four days.

  • Access to Document (DOI)

全件表示 >>

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

KOARA（リポジトリ）収録論文等 【 表示 ／ 非表示 】

• Assisted reproductive technology represents a possible risk factor for development of epimutation-mediated imprinting disorders for mothers aged ≥ 30 years (要約)

  原, 香織

  （慶應義塾大学大学院医学研究科）  2021年

• Assisted reproductive technology represents a possible risk factor for development of epimutation-mediated imprinting disorders for mothers aged ≥ 30 years (要旨)

  原, 香織

  （慶應義塾大学大学院医学研究科）  2021年

• Assisted reproductive technology represents a possible risk factor for development of epimutation-mediated imprinting disorders for mothers aged ≥ 30 years (審査報告)

  原, 香織

  （慶應義塾大学大学院医学研究科）  2021年

競争的研究費の研究課題 【 表示 ／ 非表示 】

競争的研究費の研究課題 【 表示 ／ 非表示 】

• 周産期におけるビタミンD誘導体 (3-epi-25(OH)D3) の役割の解明

  2025年04月

  -

  2028年03月

  研究代表者

受賞 【 表示 ／ 非表示 】

受賞 【 表示 ／ 非表示 】

• 2022年度臨床研究Award

  2022年06月, 日本周産期・新生児医学会, 早期新生児期から開始するビタミンD週1回投与により、乳児のVitamin D insufficiency を予防できるか

  受賞区分： 国内学会・会議・シンポジウム等の賞

• 第3回SMF論文表彰制度奨励賞

  2021年11月, 杉山記念財団, 30歳以上の女性における生殖補助医療はエピ変異によるインプリンティング疾患発症のリスク因子と成り得る

  受賞区分： 出版社・新聞社・財団等の賞

• 第43回日本小児遺伝学会大会長賞

  2021年01月, 日本小児遺伝学会, 30歳以上の女性における生殖補助医療はエピ変異によるインプリンティング疾患発症のリスク因子と成り得る

  受賞区分： 国内学会・会議・シンポジウム等の賞